Edition:
India

Zynerba Pharmaceuticals Inc (ZYNE.OQ)

ZYNE.OQ on NASDAQ Stock Exchange Global Market

9.62USD
16 Jul 2018
Change (% chg)

$-0.79 (-7.59%)
Prev Close
$10.41
Open
$10.42
Day's High
$10.53
Day's Low
$9.52
Volume
51,155
Avg. Vol
83,126
52-wk High
$20.00
52-wk Low
$5.42

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.74 December 17 Jul 2018

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 3 3 3 4
(3) HOLD 1 2 2 2
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.83 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 6 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 6 0.00 0.00 0.00 0.00
Year Ending Dec-18 6 0.00 0.00 0.00 0.38
Year Ending Dec-19 5 0.00 0.00 0.00 3.10
Earnings (per share)
Quarter Ending Sep-18 6 -0.74 -0.59 -0.96 -0.72
Quarter Ending Dec-18 6 -0.73 -0.57 -0.90 -0.73
Year Ending Dec-18 6 -3.11 -2.73 -3.57 -2.73
Year Ending Dec-19 5 -3.05 -2.57 -4.34 -2.69

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Mar-18 0.00 0.00 0.00 0.00
Quarter Ending Dec-17 0.00 0.00 0.00 0.00
Quarter Ending Sep-17 0.03 0.00 0.03 100.00
Quarter Ending Jun-17 0.05 0.00 0.05 100.00
Quarter Ending Mar-17 0.08 0.00 0.08 100.00

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Sep-18 0.00 0.00 0.00 0.00 0.00
Quarter Ending Dec-18 0.00 0.00 0.00 0.00 0.00
Year Ending Dec-18 0.00 0.00 0.00 0.00 0.38
Year Ending Dec-19 0.00 0.00 0.00 0.00 3.10

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Sep-18 0 0 0 0
Quarter Ending Dec-18 0 0 0 0
Year Ending Dec-18 0 0 0 0
Year Ending Dec-19 0 0 0 0
Earnings